- Report
- December 2024
- 150 Pages
Global
From €5408EUR$5,950USD£4,631GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- January 2025
- 187 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- February 2024
- 120 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- October 2021
- 248 Pages
Global
From €3272EUR$3,600USD£2,802GBP
- Report
- October 2021
- 82 Pages
North America
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 92 Pages
Middle East, Africa
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 95 Pages
Asia Pacific
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 94 Pages
Europe
From €1363EUR$1,500USD£1,167GBP
The Veterinary Dermatology Drugs market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and distribution of drugs used to treat skin conditions in animals. These drugs are used to treat a variety of skin conditions, including allergies, infections, and parasites. Veterinary dermatology drugs are typically administered orally, topically, or through injections. They are designed to reduce inflammation, reduce itching, and promote healing.
The Veterinary Dermatology Drugs market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Zoetis, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, and Virbac. These companies are focused on developing innovative products to meet the needs of veterinarians and pet owners. Show Less Read more
